12:00 AM
 | 
Mar 19, 2012
 |  BC Week In Review  |  Company News  |  Other News

Biogen Idec, Elan, Bristol-Myers, Pfizer, Roche autoimmune news

The PML Consortium, comprised of the companies, is reviewing research grant proposals on the pathogenesis, diagnosis and treatment of progressive multifocal leukoencephalopathy (PML), as well as the identification of risk factors. The consortium said its...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >